Copyright
©The Author(s) 2024.
World J Clin Oncol. Mar 24, 2024; 15(3): 391-410
Published online Mar 24, 2024. doi: 10.5306/wjco.v15.i3.391
Published online Mar 24, 2024. doi: 10.5306/wjco.v15.i3.391
Table 2 Hub gene differentially expressed between normal and cancer epithelial cells
Gene | P value | Avg_log2FC | Pct.1 | Pct.2 | P value adjustment |
PROM2 | 9.48E-134 | 0.115125977 | 0.096 | 0.017 | 1.98E-129 |
SLC7A11 | 2.96E-77 | -0.101678852 | 0.016 | 0.08 | 6.18E-73 |
FANCD2 | 4.01E-27 | 0.028728862 | 0.025 | 0.006 | 8.38E-23 |
- Citation: Shi JY, Che X, Wen R, Hou SJ, Xi YJ, Feng YQ, Wang LX, Liu SJ, Lv WH, Zhang YF. Ferroptosis biomarkers predict tumor mutation burden's impact on prognosis in HER2-positive breast cancer. World J Clin Oncol 2024; 15(3): 391-410
- URL: https://www.wjgnet.com/2218-4333/full/v15/i3/391.htm
- DOI: https://dx.doi.org/10.5306/wjco.v15.i3.391